• Je něco špatně v tomto záznamu ?

In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region

R. Belanova, A. Sprlakova-Pukova, M. Standara, E. Janu, R. Koukalova, J. Kristek, P. Burkon, I. Kolouskova, T. Prochazka, P. Pospisil, A. Chakravarti, P. Slampa, O. Slaby, T. Kazda

. 2020 ; 164 (3) : 307-313. [pub] 20190913

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21021187

BACKGROUND AND AIM: Oncologists play a vital role in the interpretation of radiographic results in glioblastoma patients. Molecular pathology and information on radiation treatment protocols among others are all important for accurate interpretation of radiology images. One important issue that may arise in interpreting such images is the phenomenon of tumor "pseudoprogression"; oncologists need to be able to distinguish this effect from true disease progression.Exact knowledge about the location of high-dose radiotherapy region is needed for valid determination of pseudoprogression according to RANO (Response Assessment in Neuro-Oncology) criteria in neurooncology. The aim of the present study was to evaluate the radiologists' understanding of a radiotherapy high-dose region in routine clinical practice since radiation oncologists do not always report 3-dimensional isodoses when ordering follow up imaging. METHODS: Eight glioblastoma patients who underwent postresection radiotherapy were included in this study. Four radiologists worked with their pre-radiotherapy planning MR, however, they were blinded to RT target volumes which were defined by radiation oncologists according to current guidelines. The aim was to draw target volume for high dose RT fields (that is the region, where they would consider that there may be a pseudoprogression in future MRI scans). Many different indices describing structure differences were analyzed in comparison with original per-protocol RT target volumes. RESULTS: The median volume for RT high dose field was 277 ccm (range 218 to 401 ccm) as defined per protocol by radiation oncologist and 87 ccm (range 32-338) as defined by radiologists (median difference of paired difference 31%, range 15-112%). The Median Dice index of similarity was 0.46 (range 0.14 - 0.78), the median Hausdorff distance 25 mm. CONCLUSION: Continuing effort to improve education on specific procedures in RT and in radiology as well as automatic tools for exporting RT targets is needed in order to increase specificity and sensitivity in response evaluation.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21021187
003      
CZ-PrNML
005      
20210916094008.0
007      
ta
008      
210806s2020 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2019.039 $2 doi
035    __
$a (PubMed)31544900
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Belanová, Renata $7 xx0238000 $u Department of Radiology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
245    10
$a In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region / $c R. Belanova, A. Sprlakova-Pukova, M. Standara, E. Janu, R. Koukalova, J. Kristek, P. Burkon, I. Kolouskova, T. Prochazka, P. Pospisil, A. Chakravarti, P. Slampa, O. Slaby, T. Kazda
504    __
$a Literatura
520    9_
$a BACKGROUND AND AIM: Oncologists play a vital role in the interpretation of radiographic results in glioblastoma patients. Molecular pathology and information on radiation treatment protocols among others are all important for accurate interpretation of radiology images. One important issue that may arise in interpreting such images is the phenomenon of tumor "pseudoprogression"; oncologists need to be able to distinguish this effect from true disease progression.Exact knowledge about the location of high-dose radiotherapy region is needed for valid determination of pseudoprogression according to RANO (Response Assessment in Neuro-Oncology) criteria in neurooncology. The aim of the present study was to evaluate the radiologists' understanding of a radiotherapy high-dose region in routine clinical practice since radiation oncologists do not always report 3-dimensional isodoses when ordering follow up imaging. METHODS: Eight glioblastoma patients who underwent postresection radiotherapy were included in this study. Four radiologists worked with their pre-radiotherapy planning MR, however, they were blinded to RT target volumes which were defined by radiation oncologists according to current guidelines. The aim was to draw target volume for high dose RT fields (that is the region, where they would consider that there may be a pseudoprogression in future MRI scans). Many different indices describing structure differences were analyzed in comparison with original per-protocol RT target volumes. RESULTS: The median volume for RT high dose field was 277 ccm (range 218 to 401 ccm) as defined per protocol by radiation oncologist and 87 ccm (range 32-338) as defined by radiologists (median difference of paired difference 31%, range 15-112%). The Median Dice index of similarity was 0.46 (range 0.14 - 0.78), the median Hausdorff distance 25 mm. CONCLUSION: Continuing effort to improve education on specific procedures in RT and in radiology as well as automatic tools for exporting RT targets is needed in order to increase specificity and sensitivity in response evaluation.
650    _2
$a dospělí $7 D000328
650    _2
$a nádory mozku $x radioterapie $7 D001932
650    _2
$a počítačová simulace $x normy $7 D003198
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glioblastom $x patofyziologie $x radioterapie $x chirurgie $7 D005909
650    _2
$a lidé $7 D006801
650    _2
$a mezisektorová spolupráce $7 D000070516
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a dávka záření $7 D011829
650    _2
$a radiační onkologové $7 D000072378
650    _2
$a radiační onkologie $x normy $7 D018787
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šprláková-Puková, Andrea $7 xx0100099 $u Department of Radiology and Nuclear Medicine, University Hospital Brno and Faculty of Medicine Masaryk Universit Brno, Jihlavska 20, 625 00 Brno, Czech Republic
700    1_
$a Standara, Michal $7 xx0141384 $u Department of Radiology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
700    1_
$a Janů, Eva $7 xx0230645 $u Department of Radiology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
700    1_
$a Koukalová, Renata $7 xx0130184 $u Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $u Department of Nuclear Medicine and PET Center, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
700    1_
$a Křístek, Jan, $d 1969- $7 xx0176003 $u Department of Radiology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
700    1_
$a Burkoň, Petr $7 xx0233520 $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
700    1_
$a Koloušková, Ivana $7 xx0264098 $u Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
700    1_
$a Procházka, Tomáš $7 xx0135122 $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
700    1_
$a Pospíšil, Petr $7 xx0173603 $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
700    1_
$a Chakravarti, Arnab $u Radiation Oncology Department, Arthur James Cancer Center, The Ohio State University, 460 W 10th Ave, Columbus, OH 43210, USA
700    1_
$a Šlampa, Pavel, $d 1960- $7 mzk2004257405 $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
700    1_
$a Slabý, Ondřej, $d 1981- $7 js20030220015 $u Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
700    1_
$a Kazda, Tomáš $7 xx0213412 $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 164, č. 3 (2020), s. 307-313
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31544900 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20210806 $b ABA008
991    __
$a 20210916094005 $b ABA008
999    __
$a ok $b bmc $g 1694794 $s 1141640
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 164 $c 3 $d 307-313 $e 20190913 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20210806

Najít záznam

Citační ukazatele

Možnosti archivace